Table 1.
Variant | Sex | M (days) | dM (%) | 90% (days) | d90% (%) | MRDT (days) | dMRDT (%) | n |
---|---|---|---|---|---|---|---|---|
No treatment (control) | males | 47 | 68 | 9.25 | 319 | |||
Fucoxanthin treatment (experiment) | males | 54* | 14.9 | 71 | 4.4 | 8.51 | −8 | 319 |
No treatment (control) | females | 65 | 83 | 7.99 | 323 | |||
Fucoxanthin treatment (experiment) | females | 69* | 6.2 | 83 | 0 | 7.94 | −0.6 | 315 |
M - Median lifespan; 90% - age of 90% mortality (maximum lifespan); MRDT - Mortality rate doubling time; dM, d90%, dMRDT - Differences between median lifespan, age of 90% mortality, and MRDT of control and experimental flies, respectively; n - Number of flies; *p < 0.001, Gehan-Breslow-Wilcoxon test